Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Piramal Pharma Ltd (PIRM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
146.90 -1.10    -0.74%
03:05:58 - Real-time Data. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE0DK501011 
S/N:  PPLPHARMA
  • Volume: 2,375,544
  • Bid/Ask: 146.75 / 146.90
  • Day's Range: 144.25 - 150.55
Piramal Pharma 146.90 -1.10 -0.74%

Piramal Pharma Ltd Company Profile

 
Get an in-depth profile of Piramal Pharma Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

6295

Equity Type

ORD

Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.

Contact Information

Address Piramal Ananta Ground Floor
Agastya Corporate Park LBS Marg, Kamani Junction, Kurla West Mumbai,400 070
India
Phone 91 22 3802 3000
Fax 91 22 3802 3084

Top Executives

Name Age Since Title
Peter Andrew Stevenson 70 2022 Independent Non-Executive Additional Director
Nandini Ajay Piramal 43 - Executive Chairperson
Vibha Paul Rishi 63 2022 Independent Non-Executive Director
Sridhar Gorthi 51 2022 Independent Non-Executive Director
Jairaj Manohar Purandare 73 2021 Independent Non Executive Director
Ramadorai Subramanian 79 - Independent Non-Executive Director
Nathalie Ann Leitch 56 2022 Non-Executive Director
Vivek Valsaraj 50 - President, CFO & Executive Whole-Time Director
Peter Daniel DeYoung 45 - CEO of Piramal Global Pharma & Director
Neeraj Bharadwaj - 2020 Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PIRM Comments

Write your thoughts about Piramal Pharma Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
jenti jokham
jenti jokham Jun 27, 2023 5:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
89.5 me aaj lunga.. kal 87 me
ramesh sikka
ramesh sikka May 04, 2023 8:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
not a buy recommendation consult your financial advisor
ramesh sikka
ramesh sikka May 04, 2023 8:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy PPL pharma for an upside target of 126 over next six months and an immediate Target of 100.
B S Thakur
B S Thakur Mar 26, 2023 7:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don't buy and don't apply write issue 41 rupees target next 6 month
Manish Shah
Manish Shah Feb 20, 2023 6:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy for Tgt.124
anuj
anuj Jan 04, 2023 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SORATHIYA SORATHIYA
SORATHIYA SORATHIYA Dec 02, 2022 9:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don't miss chance Piramal Group
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email